Pharmacogenomics in Clinical Therapeutics
![Pharmacogenomics in Clinical Therapeutics](http://ec4.images-amazon.com/images/I/51rMegWZGSL._SL500_AA300_.jpg)
分類: 图书,进口原版,Medicine(医学),Pharmacology(药理学),
品牌: Loralie J. LangmanAmitava Dasgupta
基本信息出版社:Wiley; 2 (2012年2月28日)精装:256页正文语种:英语ISBN:0470657340条形码:9780470657348商品尺寸:19.6 x 1.9 x 24.5 cm商品重量:689 gASIN:0470657340商品描述内容简介Pharmacogenomics is the process of analyzing patients' genes to predict the onset of adverse reactions or forecast the effectiveness of therapeutic drugs. This useful text is written to discuss both the theory and the clinical application of the principles of pharmacogenomics. Current research has clearly established that a range of treatments may be greatly improved through genetic profiling of individual patients before certain therapies begin. Aimed at clinicians, pharmacologists, and clinical laboratory professionals this book discusses the important role of laboratory tests in the practice of personalized medicine. An important new book,Pharmacogenomics in Clinical Therapeuticsserves as a guide to the basic principles of pharmacogenomics in a range of common therapeutic areas and as the basis of the personalized medicine of the future.目录List of Contributors, viiPreface, ix1 Pharmacogenomics Principles: Introduction to Personalized Medicine, 1
Parvaz Madadi, PhD and Gideon Koren, MD2 Traditional Therapeutic Drug Monitoring and Pharmacogenomics: Are They Complementary? 15
Christine L.H. Snozek, PhD, Loralie J. Langman, PhD, and Amitava Dasgupta, Ph.D3 Pharmacogenomics Aspect of Warfarin Therapy, 26
Matthew D. Krasowski, MD, PhD4 Pharmacogenetics and Cancer Chemotherapy, 39
Christine L.H. Snozek5 Pharmacogenomic Considerations in Anesthesia and Pain Management, 53
Christine M. Formea, PharmD and Wayne T. Nicholson, MD, PharmD6 Pharmacogenomics of Immunosuppressants, 70
Nicolas Picard, PharmD, PhD and Pierre Marquet, MD, PhD7 Pharmacogenomics of Cardiovascular Drugs, 98
Linnea M. Baudhuin, PhD8 Pharmacogenomic Aspects of Antiretroviral Therapy, 127
Natella Y. Rakhmanina, MD, PhD and John N. van den Anker, MD, PhD9 Pharmacogenetics of Psychoactive Drugs, 144
Jorge L. Sepulveda, MD, PhD10 Pharmacogenomic Aspects of Adverse Drug–Drug Interactions, 176
Loralie J. Langman, PhD and Christine L.H. Snozek, PhD11 Microarray Technology and Other Methods in Pharmacogenomics Testing, 185
Jorge L. Sepulveda, MD, PhD12 Pharmacogenetic Testing in the Clinical Laboratory Environment, 201
Mark P. Borgman, PhD and Mark W. Linder, PhDIndex, 225